{"id":991397,"date":"2026-08-06T13:32:27","date_gmt":"2026-08-06T17:32:27","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/outlook-therapeutics-to-report-third-quarter-fiscal-year-2026-financial-results-and-host-a-corporate-update-conference-call-and-webcast-on-august-14-2026\/"},"modified":"2026-08-06T13:32:27","modified_gmt":"2026-08-06T17:32:27","slug":"outlook-therapeutics-to-report-third-quarter-fiscal-year-2026-financial-results-and-host-a-corporate-update-conference-call-and-webcast-on-august-14-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/outlook-therapeutics-to-report-third-quarter-fiscal-year-2026-financial-results-and-host-a-corporate-update-conference-call-and-webcast-on-august-14-2026\/","title":{"rendered":"Outlook Therapeutics to Report Third Quarter Fiscal Year 2026 Financial Results and Host a Corporate Update Conference Call and Webcast on August 14, 2026"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">ISELIN, N.J., Aug.  06, 2026  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=W_Yj5S30bzpnaffqG6p7WxMFUwCc-WRm29CZ_YCtUwUzDSLEDwBaycE0t8XSLb-FG2GZQBNlekyO_qbLrp_4pmWJyI0B60D_HoBCnt2AInZb7XT_HKW9b7BQbM4ciDMH\" rel=\"nofollow\" target=\"_blank\">Outlook Therapeutics, Inc.<\/a> (Nasdaq: OTLK), a biopharmaceutical company focused on the development and commercialization of LYTENAVA\u2122 (bevacizumab-vikg, bevacizumab gamma) for the treatment of retinal diseases, today announced that it will report its financial results for the third quarter fiscal year 2026 and will host a corporate update conference call and webcast on Friday, August 14, 2026, at 8:30 AM ET.<\/p>\n<p align=\"justify\">The call will be hosted by members of Outlook Therapeutics\u2019 leadership team, Bob Jahr, Chief Executive Officer, and Lawrence A. Kenyon, Executive Vice President and Chief Financial Officer. Interested participants and investors may access the conference call by dialing 877-407-8291 (domestic) or +1 201-689-8345 (international) and referencing the Outlook Therapeutics conference call. The webcast will be accessible on the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=bAcUNFvxhJhpEuMUf50GdmFJYkUHvlha5m-5_7cxCDJYWlLmCAQP9VAmpnc6otAlh18bOuag7P6gFjYCF8P0C6vGZHIMxwmsFru9svjmrDDxTe_LUkOcCStFqizSsOIikIeAkapNT2hul1Vez_oA8g==\" rel=\"nofollow\" target=\"_blank\">Events<\/a> page of the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nVcoEDPPeCPV9XC76gxeVnPm-TmC18zIxcEskl6Fe6vUr-xoF8hjZ_4DWYuOo-G98usyiaUJxUwetGQ5qOf7qmNTTHi0vHqqtfUzTOdGGKk=\" rel=\"nofollow\" target=\"_blank\">Investor<\/a> section of the Outlook Therapeutics website, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JIA_b20fAZ_xqN_9RARAkDnhIF7d0F7DAdyKiK4KsEt9sUASfJrVcJz6QJOXTAxUeIuRnzFxsO-cY6Kmqf6VHTrz8W4iOIV_oc13myy9RbLARUjOcrVLigep2mTpK6HW\" rel=\"nofollow\" target=\"_blank\">outlooktherapeutics.com<\/a>. It will also accessible <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tdR3knFR-DoX6ga60fAhpI8MUUXUOUzbNKh5cYQPR-X5Me3QAiNJX3MIzNRFuLy1GeMCX8fiLhVroB-AB1kms8Vf0DJAGnUKSk6QfZBl7PeIBfZcs8FCVQRJNZnJRXQPiJIrlNJI4ZInJlu2kepVYA==\" rel=\"nofollow\" target=\"_blank\">here<\/a> and will be archived for 90 days.<\/p>\n<p>\n        <strong>About Outlook Therapeutics, Inc.<\/strong>\n      <\/p>\n<p align=\"justify\">Outlook Therapeutics is a biopharmaceutical company focused on the development and commercialization of LYTENAVA\u2122 (bevacizumab-vikg (U.S.), bevacizumab gamma (E.U.)). LYTENAVA\u2122 is the first ophthalmic formulation of bevacizumab to receive U.S. FDA approval and European Commission and MHRA Marketing Authorization for the treatment of wet AMD. Outlook Therapeutics commenced commercial launch of LYTENAVA\u2122 (bevacizumab gamma) in Germany, Austria, and the UK as a treatment for wet AMD.<\/p>\n<p>\n        <strong>Investor Inquiries:<\/strong>\n      <\/p>\n<p>Jenene Thomas<\/p>\n<p>Chief Executive Officer<\/p>\n<p>JTC Team, LLC<\/p>\n<p>T: 908.824.0775<\/p>\n<p>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3qmOPYxFVbTxCyzvtrav81lH996Rq3V50xYhhtI-1IxMpeXr5VHiHsPbXBlGK65u-kZtEjIKLtxLLW0p9hodsQ==\" rel=\"nofollow\" target=\"_blank\">OTLK@jtcir.com<\/a>\n      <\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwNDgxMSM3NzYyMDQ1IzIwMjg4MjI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NjQ5YWMxYTktZDI3MS00MzBiLWFiMjAtYjZmMThiMTAzZTE5LTEwNDAzOTMtMjAyNi0wOC0wNi1lbg==\/tiny\/Outlook-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ISELIN, N.J., Aug. 06, 2026 (GLOBE NEWSWIRE) &#8212; Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on the development and commercialization of LYTENAVA\u2122 (bevacizumab-vikg, bevacizumab gamma) for the treatment of retinal diseases, today announced that it will report its financial results for the third quarter fiscal year 2026 and will host a corporate update conference call and webcast on Friday, August 14, 2026, at 8:30 AM ET. The call will be hosted by members of Outlook Therapeutics\u2019 leadership team, Bob Jahr, Chief Executive Officer, and Lawrence A. Kenyon, Executive Vice President and Chief Financial Officer. Interested participants and investors may access the conference call by dialing 877-407-8291 (domestic) or +1 201-689-8345 (international) and referencing the Outlook Therapeutics conference call. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/outlook-therapeutics-to-report-third-quarter-fiscal-year-2026-financial-results-and-host-a-corporate-update-conference-call-and-webcast-on-august-14-2026\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Outlook Therapeutics to Report Third Quarter Fiscal Year 2026 Financial Results and Host a Corporate Update Conference Call and Webcast on August 14, 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-991397","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Outlook Therapeutics to Report Third Quarter Fiscal Year 2026 Financial Results and Host a Corporate Update Conference Call and Webcast on August 14, 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/outlook-therapeutics-to-report-third-quarter-fiscal-year-2026-financial-results-and-host-a-corporate-update-conference-call-and-webcast-on-august-14-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Outlook Therapeutics to Report Third Quarter Fiscal Year 2026 Financial Results and Host a Corporate Update Conference Call and Webcast on August 14, 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ISELIN, N.J., Aug. 06, 2026 (GLOBE NEWSWIRE) &#8212; Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on the development and commercialization of LYTENAVA\u2122 (bevacizumab-vikg, bevacizumab gamma) for the treatment of retinal diseases, today announced that it will report its financial results for the third quarter fiscal year 2026 and will host a corporate update conference call and webcast on Friday, August 14, 2026, at 8:30 AM ET. The call will be hosted by members of Outlook Therapeutics\u2019 leadership team, Bob Jahr, Chief Executive Officer, and Lawrence A. Kenyon, Executive Vice President and Chief Financial Officer. Interested participants and investors may access the conference call by dialing 877-407-8291 (domestic) or +1 201-689-8345 (international) and referencing the Outlook Therapeutics conference call. &hellip; Continue reading &quot;Outlook Therapeutics to Report Third Quarter Fiscal Year 2026 Financial Results and Host a Corporate Update Conference Call and Webcast on August 14, 2026&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/outlook-therapeutics-to-report-third-quarter-fiscal-year-2026-financial-results-and-host-a-corporate-update-conference-call-and-webcast-on-august-14-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-06T17:32:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwNDgxMSM3NzYyMDQ1IzIwMjg4MjI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/outlook-therapeutics-to-report-third-quarter-fiscal-year-2026-financial-results-and-host-a-corporate-update-conference-call-and-webcast-on-august-14-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/outlook-therapeutics-to-report-third-quarter-fiscal-year-2026-financial-results-and-host-a-corporate-update-conference-call-and-webcast-on-august-14-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Outlook Therapeutics to Report Third Quarter Fiscal Year 2026 Financial Results and Host a Corporate Update Conference Call and Webcast on August 14, 2026\",\"datePublished\":\"2026-08-06T17:32:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/outlook-therapeutics-to-report-third-quarter-fiscal-year-2026-financial-results-and-host-a-corporate-update-conference-call-and-webcast-on-august-14-2026\\\/\"},\"wordCount\":255,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/outlook-therapeutics-to-report-third-quarter-fiscal-year-2026-financial-results-and-host-a-corporate-update-conference-call-and-webcast-on-august-14-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwNDgxMSM3NzYyMDQ1IzIwMjg4MjI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/outlook-therapeutics-to-report-third-quarter-fiscal-year-2026-financial-results-and-host-a-corporate-update-conference-call-and-webcast-on-august-14-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/outlook-therapeutics-to-report-third-quarter-fiscal-year-2026-financial-results-and-host-a-corporate-update-conference-call-and-webcast-on-august-14-2026\\\/\",\"name\":\"Outlook Therapeutics to Report Third Quarter Fiscal Year 2026 Financial Results and Host a Corporate Update Conference Call and Webcast on August 14, 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/outlook-therapeutics-to-report-third-quarter-fiscal-year-2026-financial-results-and-host-a-corporate-update-conference-call-and-webcast-on-august-14-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/outlook-therapeutics-to-report-third-quarter-fiscal-year-2026-financial-results-and-host-a-corporate-update-conference-call-and-webcast-on-august-14-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwNDgxMSM3NzYyMDQ1IzIwMjg4MjI=\",\"datePublished\":\"2026-08-06T17:32:27+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/outlook-therapeutics-to-report-third-quarter-fiscal-year-2026-financial-results-and-host-a-corporate-update-conference-call-and-webcast-on-august-14-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/outlook-therapeutics-to-report-third-quarter-fiscal-year-2026-financial-results-and-host-a-corporate-update-conference-call-and-webcast-on-august-14-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/outlook-therapeutics-to-report-third-quarter-fiscal-year-2026-financial-results-and-host-a-corporate-update-conference-call-and-webcast-on-august-14-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwNDgxMSM3NzYyMDQ1IzIwMjg4MjI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwNDgxMSM3NzYyMDQ1IzIwMjg4MjI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/outlook-therapeutics-to-report-third-quarter-fiscal-year-2026-financial-results-and-host-a-corporate-update-conference-call-and-webcast-on-august-14-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Outlook Therapeutics to Report Third Quarter Fiscal Year 2026 Financial Results and Host a Corporate Update Conference Call and Webcast on August 14, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Outlook Therapeutics to Report Third Quarter Fiscal Year 2026 Financial Results and Host a Corporate Update Conference Call and Webcast on August 14, 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/outlook-therapeutics-to-report-third-quarter-fiscal-year-2026-financial-results-and-host-a-corporate-update-conference-call-and-webcast-on-august-14-2026\/","og_locale":"en_US","og_type":"article","og_title":"Outlook Therapeutics to Report Third Quarter Fiscal Year 2026 Financial Results and Host a Corporate Update Conference Call and Webcast on August 14, 2026 - Market Newsdesk","og_description":"ISELIN, N.J., Aug. 06, 2026 (GLOBE NEWSWIRE) &#8212; Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on the development and commercialization of LYTENAVA\u2122 (bevacizumab-vikg, bevacizumab gamma) for the treatment of retinal diseases, today announced that it will report its financial results for the third quarter fiscal year 2026 and will host a corporate update conference call and webcast on Friday, August 14, 2026, at 8:30 AM ET. The call will be hosted by members of Outlook Therapeutics\u2019 leadership team, Bob Jahr, Chief Executive Officer, and Lawrence A. Kenyon, Executive Vice President and Chief Financial Officer. Interested participants and investors may access the conference call by dialing 877-407-8291 (domestic) or +1 201-689-8345 (international) and referencing the Outlook Therapeutics conference call. &hellip; Continue reading \"Outlook Therapeutics to Report Third Quarter Fiscal Year 2026 Financial Results and Host a Corporate Update Conference Call and Webcast on August 14, 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/outlook-therapeutics-to-report-third-quarter-fiscal-year-2026-financial-results-and-host-a-corporate-update-conference-call-and-webcast-on-august-14-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-08-06T17:32:27+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwNDgxMSM3NzYyMDQ1IzIwMjg4MjI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/outlook-therapeutics-to-report-third-quarter-fiscal-year-2026-financial-results-and-host-a-corporate-update-conference-call-and-webcast-on-august-14-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/outlook-therapeutics-to-report-third-quarter-fiscal-year-2026-financial-results-and-host-a-corporate-update-conference-call-and-webcast-on-august-14-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Outlook Therapeutics to Report Third Quarter Fiscal Year 2026 Financial Results and Host a Corporate Update Conference Call and Webcast on August 14, 2026","datePublished":"2026-08-06T17:32:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/outlook-therapeutics-to-report-third-quarter-fiscal-year-2026-financial-results-and-host-a-corporate-update-conference-call-and-webcast-on-august-14-2026\/"},"wordCount":255,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/outlook-therapeutics-to-report-third-quarter-fiscal-year-2026-financial-results-and-host-a-corporate-update-conference-call-and-webcast-on-august-14-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwNDgxMSM3NzYyMDQ1IzIwMjg4MjI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/outlook-therapeutics-to-report-third-quarter-fiscal-year-2026-financial-results-and-host-a-corporate-update-conference-call-and-webcast-on-august-14-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/outlook-therapeutics-to-report-third-quarter-fiscal-year-2026-financial-results-and-host-a-corporate-update-conference-call-and-webcast-on-august-14-2026\/","name":"Outlook Therapeutics to Report Third Quarter Fiscal Year 2026 Financial Results and Host a Corporate Update Conference Call and Webcast on August 14, 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/outlook-therapeutics-to-report-third-quarter-fiscal-year-2026-financial-results-and-host-a-corporate-update-conference-call-and-webcast-on-august-14-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/outlook-therapeutics-to-report-third-quarter-fiscal-year-2026-financial-results-and-host-a-corporate-update-conference-call-and-webcast-on-august-14-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwNDgxMSM3NzYyMDQ1IzIwMjg4MjI=","datePublished":"2026-08-06T17:32:27+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/outlook-therapeutics-to-report-third-quarter-fiscal-year-2026-financial-results-and-host-a-corporate-update-conference-call-and-webcast-on-august-14-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/outlook-therapeutics-to-report-third-quarter-fiscal-year-2026-financial-results-and-host-a-corporate-update-conference-call-and-webcast-on-august-14-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/outlook-therapeutics-to-report-third-quarter-fiscal-year-2026-financial-results-and-host-a-corporate-update-conference-call-and-webcast-on-august-14-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwNDgxMSM3NzYyMDQ1IzIwMjg4MjI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwNDgxMSM3NzYyMDQ1IzIwMjg4MjI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/outlook-therapeutics-to-report-third-quarter-fiscal-year-2026-financial-results-and-host-a-corporate-update-conference-call-and-webcast-on-august-14-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Outlook Therapeutics to Report Third Quarter Fiscal Year 2026 Financial Results and Host a Corporate Update Conference Call and Webcast on August 14, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/991397","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=991397"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/991397\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=991397"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=991397"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=991397"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}